VAR2 Pharmaceuticals APS
5Patents
5Active
5Granted
44Portfolio score
Filing activity: Feb 8, 2013 → Oct 4, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9926350B2 | Targeting of chondroitin sulfate glycans | Emerging Cross-Sectional Technologies | 1 | Active |
| US11787844B2 | Targeting of chondroitin sulfate glycans | Emerging Cross-Sectional Technologies | 0 | Active |
| US10517958B2 | Compositions and methods for the treatment of platinum-drug resistant cancer | Human Necessities | 0 | Active |
| US9932375B2 | Targeting of chondroitin sulfate glycans | Emerging Cross-Sectional Technologies | 0 | Active |
| US10675355B2 | VAR2CSA-drug conjugates | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.